MedPath

The Clinical Study of Silicone Hydrogel Daily Disposable Stenfilcon A Toric Lens

Not Applicable
Completed
Conditions
Astigmatism
Interventions
Device: etafilcon A
Device: stenfilcon A
Registration Number
NCT02801006
Lead Sponsor
Coopervision, Inc.
Brief Summary

The aim of this study is to evaluate the clinical performance of stenfilcon A toric lenses compared with etafilcon A toric lenses for astigmatism. If it is valuable, the clinical performance of stenfilcon A toric lens is also evaluated compared with habitual lenses.

Detailed Description

This is a multi-sites, 50 subjects, randomized, open labeled, bilateral wear, dispensing study. Participants will be randomized to wear first lens pair for two weeks, and then crossover to second lens pair for two weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria

A person is eligible for inclusion in the study if he/she:

  • Is between 18 years of age and 42 years of age.
  • Soft contact lens wearers who are not required to have Presbyopic correction.
  • Soft contact lens wearers without trouble.
  • Soft contact lens wearers who have the correctable astigmatism by lenses used in this study in the both eyes.
  • Has a prescribed SCL (Soft Contact Lens) power within the range of powers of the SCL for astigmatism which is used in this study.
  • Can achieve a corrected visual acuity of 1.0 or better.
  • Can read and understand the study information document, and sign the participation consent form.
  • Can visit the clinic at designated examination visits.
  • Has received periodical examinations at an eye clinic within the past two years.
Exclusion Criteria

A person will be excluded from the study if he/she:

  • Has a systemic disease that may affect the ocular health.
  • Is pregnant or lactating.
  • Has received a systemic or local medication that may affect this study.
  • Has an infectious eye disease.
  • Has eye and systemic active allergic diseases that interferes with SCL wear.
  • Has an eye disease which is clinically judged to be severe such as corneal vascularization, limbal hyperemia, and corneal epithelium disorder
  • Has a history of hard contact lens wear within 30 days.
  • Is currently participating in another clinical research study.
  • Has undergone refractive surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
etafilcon Aetafilcon AParticipants will be randomized to wear etafilcon A lens pair for two weeks during the cross over study.
stenfilcon Astenfilcon AParticipants will be randomized to wear stenfilcon A lens pair for two weeks during the cross over study.
Primary Outcome Measures
NameTimeMethod
Comfort2 weeks

Wearing comfort (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0= extremely uncomfortable cannot wear at all, 10=very comfortable and feel no lens at all

Dryness2 weeks

Dryness (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=extremely dried and cannot wear lens, 10=feel no dryness at all

Stability of Vision2 weeks

Stability of vision (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=unstable vision and cannot see at all, 10=always stable vision

Clarity of Vision2 weeks

Clarity of vision (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=blur vision and cannot see at all, 10=very clear with no blur vision at all

Lens Handling2 weeks

Lens handling for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=cannot handle at all, 10=no problem at all

Overall Satisfaction2 weeks

Overall satisfaction for stenfilcon A and etafilcon A toric lens pair is assessed. scale 0-10, 0=extremely un-satisfy, 10=very satisfy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Kodama Eye Clinic

🇯🇵

Terada, Kyoto, Japan

Dougenzaka Ioti Eye Clinic

🇯🇵

Shibuya, Tokyo-to, Japan

© Copyright 2025. All Rights Reserved by MedPath